Ferrous Sulfate vs Iron Bisglycinate
How ferrous sulfate and iron bisglycinate differ in elemental content, absorption, tolerance, and cost.
This page contains affiliate links. Titrate earns a small commission when you purchase through them, at no cost to you. This does not affect our recommendations.
Side by Side
| Ferrous Sulfate | Iron Bisglycinate | |
|---|---|---|
| Elemental content | 20% elemental iron | 20% elemental iron |
| Absorption | High | High |
| How it is absorbed | Ferrous (Fe2+) iron is absorbed by divalent metal transporter 1 (DMT1) in the duodenum. Absorption rises when stores are low and falls as hepcidin rises after a dose. | Iron chelated to two glycine molecules. The chelate is less affected by dietary phytates than iron salts, and absorption remains regulated by iron status. |
| Typical dose | 40-65 mg elemental iron daily or on alternate days for deficiency | 25-50 mg elemental iron daily |
| Common uses | iron deficiency anemia, first-line oral repletion | iron deficiency with GI intolerance to salts, pregnancy |
| Side effects | Nausea, constipation, dark stools, epigastric pain; dose-dependent. | Typically fewer GI complaints than ferrous sulfate in trials, partly due to lower doses. |
| Cost | Low | Moderate |
| Also called | iron sulfate | ferrous bisglycinate chelate, Ferrochel, gentle iron |
| Labels in index | 101 | 283 |
When to Choose Ferrous Sulfate
Choose ferrous sulfate when you want the cheapest proven repletion and tolerate it. The reference form against which others are compared. A single morning dose on alternate days improved fractional absorption versus daily dosing in Stoffel 2017.
Ferrous Sulfate
The reference standard: cheapest, best studied, and the form used in the hepcidin dosing trials. GI side effects are the price.
What to look for: 65 mg elemental iron (325 mg tablet), not enteric coated, taken once in the morning on alternate days.
Find on iHerb Affiliate linkWhen to Choose Iron Bisglycinate
Choose iron bisglycinate when ferrous salts cause GI side effects. Often the switch when sulfate causes constipation or nausea.
Iron Bisglycinate
Easier on the stomach for many people. Fewer head-to-head data than sulfate.
What to look for: Elemental iron stated per capsule, often 25-36 mg. Ferrochel is the most studied raw material.
Find on iHerb Affiliate linkProducts on Titrate
In Titrate's index of NIH label data, 101 labels named as iron products list ferrous sulfate and 283 list iron bisglycinate.
Iron does not have its own search category yet. Each product above links to its full label in the NIH database.
Related
- Iron supplement guide
- Iron Absorption Estimator
- Supplement Timing Optimizer
- Carbonyl Iron vs Ferrous Sulfate
- Carbonyl Iron vs Iron Bisglycinate
- Ferrous Fumarate vs Ferrous Sulfate
- Ferrous Fumarate vs Iron Bisglycinate
- Ferrous Gluconate vs Ferrous Sulfate
- Ferrous Gluconate vs Iron Bisglycinate
- All form comparisons
References
NIH Office of Dietary Supplements. Iron: Fact Sheet for Health Professionals.
Hallberg L, Brune M, Rossander L. Iron absorption in man: ascorbic acid and dose-dependent inhibition by phytate. Am J Clin Nutr. 1989;49(1):140-144.
Moretti D, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126(17):1981-1989.
Tolkien Z, et al. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383.
Stoffel NU, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4(11):e524-e533.
Stoffel NU, et al. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. 2020;105(5):1232-1239.
World Health Organization. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: WHO; 2020.